{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-239193","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2024-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.809655+00:00","generated_at":"2026-05-30T12:54:28.006311+00:00","sec_items":["2.02","7.01","5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"David Joyner named CVS Health CEO replacing Karen Lynch; preliminary Q3 EPS guide weak","bullets":["David Joyner appointed President and CEO effective Oct. 17, 2024, succeeding Karen Lynch who resigned.","Roger Farah elevated to Executive Chairman of the Board.","Preliminary Q3 2024 GAAP diluted EPS $0.03-$0.08; adjusted EPS $1.05-$1.10.","Results include $1.1B premium deficiency reserve charge and $1.2B restructuring charge.","MBR expected ~95.2%; prior guidance withdrawn due to elevated medical cost trends."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-239193","json":"https://secwatch.observer/filing/0001193125-24-239193.json","markdown":"https://secwatch.observer/filing/0001193125-24-239193.md","text":"https://secwatch.observer/filing/0001193125-24-239193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/0001193125-24-239193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/d837701d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:54:28.006311+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"03e0b2c5b6","claim":"Karen S. Lynch resigned as President and Chief Executive Officer at CVS HEALTH Corp.","evidence_excerpt":"Karen S. Lynch ceased to serve as President and Chief Executive Officer of the Company and resigned as a member of the Board on the same day.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/0001193125-24-239193-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"ad8b8d7352","claim":"Roger N. Farah was appointed as Executive Chairman of the Board at CVS HEALTH Corp.","evidence_excerpt":"Effective October 17, 2024, the Board has also appointed current Chairman Roger N. Farah as Executive Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/0001193125-24-239193-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"e098b5dfaa","claim":"J. David Joyner was appointed as President and Chief Executive Officer at CVS HEALTH Corp.","evidence_excerpt":"the Board of Directors (the “ Board ”) of the Company appointed J. David Joyner as President and Chief Executive Officer of the Company, effective as of October 17, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/0001193125-24-239193-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}